Jeff Fairman - Mar 2, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
VP, Research
Signature
/s/ Ron Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Mar 2, 2022
Transactions value $
$0
Form type
4
Date filed
3/4/2022, 07:56 PM
Previous filing
Dec 28, 2021
Next filing
Mar 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Award $0 +6K +56.45% $0.00 16.6K Mar 2, 2022 Direct F1
holding PCVX Common Stock 341K Mar 2, 2022 By Fairman Family Trust
holding PCVX Common Stock 50K Mar 2, 2022 By AF 2020 Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Award $0 +33K $0.00 33K Mar 2, 2022 Common Stock 33K $24.79 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2022 and 12.5% of the shares every six months thereafter.
F2 1/48 of shares subject to the option vest on April 2, 2022, and 1/48 of the shares vest monthly thereafter.